These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 17610223)
1. Signal transducer and activator of transcription 3 (Stat3) in epithelial carcinogenesis. Kim DJ; Chan KS; Sano S; Digiovanni J Mol Carcinog; 2007 Aug; 46(8):725-31. PubMed ID: 17610223 [TBL] [Abstract][Full Text] [Related]
2. Signal transducer and activator of transcription 3 is a key regulator of keratinocyte survival and proliferation following UV irradiation. Sano S; Chan KS; Kira M; Kataoka K; Takagi S; Tarutani M; Itami S; Kiguchi K; Yokoi M; Sugasawa K; Mori T; Hanaoka F; Takeda J; DiGiovanni J Cancer Res; 2005 Jul; 65(13):5720-9. PubMed ID: 15994947 [TBL] [Abstract][Full Text] [Related]
3. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis. Chan KS; Sano S; Kataoka K; Abel E; Carbajal S; Beltran L; Clifford J; Peavey M; Shen J; Digiovanni J Oncogene; 2008 Feb; 27(8):1087-94. PubMed ID: 17700521 [TBL] [Abstract][Full Text] [Related]
4. Impact of Stat3 activation upon skin biology: a dichotomy of its role between homeostasis and diseases. Sano S; Chan KS; DiGiovanni J J Dermatol Sci; 2008 Apr; 50(1):1-14. PubMed ID: 17601706 [TBL] [Abstract][Full Text] [Related]
6. Keratinocyte-specific stat3 heterozygosity impairs development of skin tumors in human papillomavirus 8 transgenic mice. De Andrea M; Rittà M; Landini MM; Borgogna C; Mondini M; Kern F; Ehrenreiter K; Baccarini M; Marcuzzi GP; Smola S; Pfister H; Landolfo S; Gariglio M Cancer Res; 2010 Oct; 70(20):7938-48. PubMed ID: 20876801 [TBL] [Abstract][Full Text] [Related]
7. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis. Rosen DG; Mercado-Uribe I; Yang G; Bast RC; Amin HM; Lai R; Liu J Cancer; 2006 Dec; 107(11):2730-40. PubMed ID: 17063503 [TBL] [Abstract][Full Text] [Related]
8. Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. Chan KS; Sano S; Kiguchi K; Anders J; Komazawa N; Takeda J; DiGiovanni J J Clin Invest; 2004 Sep; 114(5):720-8. PubMed ID: 15343391 [TBL] [Abstract][Full Text] [Related]
9. Stat3 activation is required for cell proliferation and tumorigenesis but not for cell viability in cutaneous squamous cell carcinoma cell lines. Sumita N; Bito T; Nakajima K; Nishigori C Exp Dermatol; 2006 Apr; 15(4):291-9. PubMed ID: 16512876 [TBL] [Abstract][Full Text] [Related]
10. Ultraviolet B exposure activates Stat3 signaling via phosphorylation at tyrosine705 in skin of SKH1 hairless mouse: a target for the management of skin cancer? Ahsan H; Aziz MH; Ahmad N Biochem Biophys Res Commun; 2005 Jul; 333(1):241-6. PubMed ID: 15936723 [TBL] [Abstract][Full Text] [Related]
11. Constitutive activation and targeted disruption of signal transducer and activator of transcription 3 (Stat3) in mouse epidermis reveal its critical role in UVB-induced skin carcinogenesis. Kim DJ; Angel JM; Sano S; DiGiovanni J Oncogene; 2009 Feb; 28(7):950-60. PubMed ID: 19137019 [TBL] [Abstract][Full Text] [Related]
12. Protein kinase C epsilon, which sensitizes skin to sun's UV radiation-induced cutaneous damage and development of squamous cell carcinomas, associates with Stat3. Aziz MH; Manoharan HT; Verma AK Cancer Res; 2007 Feb; 67(3):1385-94. PubMed ID: 17283176 [TBL] [Abstract][Full Text] [Related]
13. Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications. Huang S Clin Cancer Res; 2007 Mar; 13(5):1362-6. PubMed ID: 17332277 [TBL] [Abstract][Full Text] [Related]
14. STAT3 as a central mediator of neoplastic cellular transformation. Frank DA Cancer Lett; 2007 Jun; 251(2):199-210. PubMed ID: 17129668 [TBL] [Abstract][Full Text] [Related]
15. Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors. Alvarez JV; Febbo PG; Ramaswamy S; Loda M; Richardson A; Frank DA Cancer Res; 2005 Jun; 65(12):5054-62. PubMed ID: 15958548 [TBL] [Abstract][Full Text] [Related]
16. Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy. Germain D; Frank DA Clin Cancer Res; 2007 Oct; 13(19):5665-9. PubMed ID: 17908954 [TBL] [Abstract][Full Text] [Related]
18. Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Aggarwal BB; Sethi G; Ahn KS; Sandur SK; Pandey MK; Kunnumakkara AB; Sung B; Ichikawa H Ann N Y Acad Sci; 2006 Dec; 1091():151-69. PubMed ID: 17341611 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of Stat3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line. Gariboldi MB; Ravizza R; Molteni R; Osella D; Gabano E; Monti E Cancer Lett; 2007 Dec; 258(2):181-8. PubMed ID: 17920763 [TBL] [Abstract][Full Text] [Related]
20. Cell density dependent increase of constitutive signal transducers and activators of transcription 3 activity in melanoma cells is mediated by Janus kinases. Kreis S; Munz GA; Haan S; Heinrich PC; Behrmann I Mol Cancer Res; 2007 Dec; 5(12):1331-41. PubMed ID: 18171991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]